Trademark: 79329443
Status Date
Tuesday, April 25, 2023
Registration Number
7033146
Registration Date
Tuesday, April 25, 2023
Filing Date
Thursday, October 21, 2021
Published for Opposition
Tuesday, February 7, 2023
9 Downloadable software for use in diagnosis of inflammatory diseases and liver diseases; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments especially for recording, processing, reproducing, transmitting data, namely, electronic data loggers and recorders; data processing equipment; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
5 Pharmaceuticals for use in human or veterinary medicine, for scientific use for the treatment of inflammatory diseases and liver diseases; chemical preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and cell therapy, namely, cell growth media; blood and blood derived samples, namely, plasma, serum, platelet free samples for medical use; diagnostic biomarker reagent products for use in human or veterinary medicine; diagnostic reagents for use in human or veterinary medicine; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
1 Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for scientific use; reagents for immunoserology and molecular diagnosis for research use; chemical reagents for genetic research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research use; diagnostic reagents for in-vitro use in biochemistry, molecular biology, clinical chemistry and microbiology for research use; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
44 Medical analysis relating to the diagnosis and treatment of persons and medical diagnosis services in inflammatory diseases and liver diseases; medical analyses of blood samples, biological preparations and biological fluids relating to the diagnosis and treatment of persons; support services in the field of medicine, health care and pharmaceutical research, namely, medical analysis for the diagnosis and treatment of patients; medical information; provision of medical information; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
10 Medical apparatus, instruments and equipment, namely, DNA, RNA and protein analysis apparatus, DNA, RNA and protein quantifiers, medical devices for measuring DNA, RNA, biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of inflammatory and liver diseases and blood analyzers for evaluation of inflammatory and liver diseases; instruments and tools for medical diagnosis, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing the biomarker levels; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
42 Pharmaceutical research, namely, research for the discovery of new medicines; scientific research, especially in the medical, biomedical, chemical, genetic, pharmaceutical field; basic and applied scientific research; technical scientific research; scientific research, namely, sorting and selection of molecules; scientific research services, namely, development and validation of biological tests, cellular tests and genetic tests; scientific research, namely, functional genomics for identifying, characterizing, validating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering services, namely, surveying; technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
Aug 3, 2023
Final Disposition Notice Sent To Ib
Aug 3, 2023
Final Disposition Processed
Jul 25, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 25, 2023
Notice Of Registration Confirmation Emailed
Apr 25, 2023
Registered-Principal Register
Feb 7, 2023
Notification Processed By Ib
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Possible Opposition Sent To Ib
Jan 18, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 17, 2023
Assigned To Examiner
Dec 31, 2022
Approved For Pub - Principal Register
Dec 31, 2022
Examiner's Amendment Entered
Dec 31, 2022
Notification Of Examiners Amendment E-Mailed
Dec 31, 2022
Examiners Amendment E-Mailed
Dec 31, 2022
Examiners Amendment -Written
Nov 27, 2022
Teas/Email Correspondence Entered
Nov 27, 2022
Correspondence Received In Law Office
Oct 24, 2022
Teas/Email Correspondence Entered
Oct 24, 2022
Correspondence Received In Law Office
Oct 24, 2022
Teas Response To Office Action Received
May 16, 2022
Refusal Processed By Ib
Apr 28, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Apr 28, 2022
Refusal Processed By Mpu
Mar 18, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 17, 2022
Non-Final Action Written
Mar 17, 2022
Assigned To Examiner
Jan 7, 2022
Application Filing Receipt Mailed
Jan 3, 2022
New Application Office Supplied Data Entered
Dec 23, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
